RESEARCHER PROFILE (Filmed May 2024)
Dr Shelley Keating AES AEP ESSAM
Senior Lecturer, Clinical Exercise Physiology and Accredited Exercise Physiologist
School of Human Movement and Nutrition Sciences
The University of Queensland
Dr Shelley Keating is a Senior Lecturer in Clinical Exercise Physiology and Accredited Exercise Physiologist from the School of Human Movement and Nutrition Sciences at the University of Queensland. With a strong grounding in exercise metabolism and body composition, Dr Keating’s research centres on the utility of exercise as a therapy for obesity and related cardiometabolic conditions, notably metabolic dysfunction-associated steatotic liver disease (MASLD).
Dr Keating has an established research profile that is delivering impact for patients and clinicians. Her research has led to the development of safe and feasible exercise programs that generate significant improvement in the cardiometabolic health of individuals with MASLD and related chronic disease. Drawing on these findings, Dr Keating has developed national and international exercise guidelines for MASLD. Her research has led to a paradigm shift in how exercise is prioritised in MASLD management and has been adopted into exercise prescription recommendations in 15 international guidelines for MASLD management across 12 countries.
Dr Keating’s research had found a lack of awareness, uptake, and sustainability of exercise for MASLD management. Her ongoing program of research is informed by, and co-designed with, people with MASLD and related chronic disease, to find sustainable exercise solutions.
Her contribution to the field was recognised by the prestigious 2020 Australia and New Zealand Obesity Society Young Investigator award. Shelley has been an ESSA (Exercise & Sports Science Australia) member since 2007 and has 16 years of clinical AEP experience in people with cardiometabolic disease including MAFLD.
Her mission is to change the way that exercise is prioritised, accessed, and delivered to improve the health and wellbeing of people with MASLD and related type 2 diabetes.
Source: Supplied & ESSA (Exercise & Sports Science Australia)
Note: AES is the acronym for Accredited Exercise Scientist (AES), AEP is the acronym for Accredited Exercise Physiologist, ESSAM is the acronym for Exercise & Sports Science Australia Member.
-
Respiratory health and the microbiome in the lung environment
Dr Taylor leads the Respiratory Health Group within the Microbiome and Host Health Program. His research employs tailored techniques that allow the lung environment to be characterised to a high level of accuracy, including detailed measurements of airway microbiology (microbiome), mucus composition, and inflammation. This information is used to identify predictive markers of chronic lung disease severity as well as determine effective forms of therapy.
-
Stem cell therapies for enteric neuropathies
Dr Stamp is a Group Leader in the Department of Anatomy and Physiology at the University of Melbourne, Australia. Dr Stamp’s PhD research (with Prof Martin Pera, Monash University) focused on the derivation of hepatopancreatic progenitors from human embryonic stem cells. He then joined the lab of Dr Don Newgreen at the Murdoch Childrens Research Institute where he began working on development of the enteric nervous system (ENS), before joining Prof Heather Young’s lab at the University of Melbourne, where he focused on developing a stem cell therapy to treat gut motility disorders such as the paediatric enteric neuropathy Hirschprung disease.
-
Novel immunotherapies in lymphoma
Dr Sean Harrop is a dual-trained haematologist having completed his clinical and laboratory haematology training at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital and St Vincent’s Hospital Melbourne. He is the current clinical haematology fellow (aggressive lymphoma) at Peter MacCallum and a PhD student in the Cancer Immunology Program in the Neeson Lab.
